Van Cleef Asset Management Inc lessened its stake in shares of UnitedHealth Group (NYSE:UNH) by 4.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,702 shares of the healthcare conglomerate’s stock after selling 444 shares during the quarter. Van Cleef Asset Management Inc’s holdings in UnitedHealth Group were worth $2,359,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the stock. Capital International Investors increased its holdings in UnitedHealth Group by 399.3% during the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares in the last quarter. Jennison Associates LLC increased its holdings in UnitedHealth Group by 146.0% during the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC increased its holdings in UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. increased its holdings in UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares in the last quarter. Finally, Parametric Portfolio Associates LLC increased its holdings in UnitedHealth Group by 77.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares in the last quarter. Institutional investors and hedge funds own 86.79% of the company’s stock.
Shares of UnitedHealth Group stock opened at $223.96 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group has a 12 month low of $164.60 and a 12 month high of $250.79. The firm has a market cap of $221,391.59, a P/E ratio of 22.24, a P/E/G ratio of 1.33 and a beta of 0.77.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same period in the previous year, the firm earned $2.11 earnings per share. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. equities research analysts anticipate that UnitedHealth Group will post 12.51 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were paid a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 29.79%.
UNH has been the subject of a number of recent analyst reports. Cantor Fitzgerald reaffirmed a “buy” rating and set a $235.00 price target on shares of UnitedHealth Group in a report on Monday, December 25th. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Goldman Sachs initiated coverage on UnitedHealth Group in a report on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target for the company. Evercore ISI reaffirmed an “outperform” rating and set a $255.00 price target (up from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Finally, Piper Jaffray reissued a “buy” rating and issued a $259.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Two research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $244.06.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction dated Monday, March 19th. The stock was sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the transaction, the director now directly owns 1,771,257 shares in the company, valued at $397,399,220.52. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Kenneth Irwin Shine sold 198 shares of UnitedHealth Group stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $242.55, for a total value of $48,024.90. Following the transaction, the director now owns 1,790,567 shares in the company, valued at $434,302,025.85. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 77,015 shares of company stock valued at $17,879,199. 0.89% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: This report was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/04/07/unitedhealth-group-inc-unh-position-reduced-by-van-cleef-asset-management-inc.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.